Product Information
OMEPRAZOLE DR 20 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.3832 per EA under NDC 68001044139. Its NADAC has been published 291 times since Mar 10, 2021.
FDA first approved this application on Nov 5, 2018.
Strength
20 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001044139
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207740FDA Approved
11/5/2018
On Market Since
6/19/2020
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE DR 20 MG TABLET has been published 291 times since Mar 10, 2021, and over the history we have for it it has declined 23.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3832 per EA |
|---|---|
| All-time high | $0.5029 (Mar 10, 2021) |
| All-time low | $0.3668 (May 22, 2024) |
| 52-week high | $0.4213 |
| 52-week low | $0.3832 |
| Median price | $0.4362 |
| Average price | $0.4315 |
| Largest weekly change | +18.4% (Aug 21, 2024) |
| Weeks tracked | 291 |
| Tracking since | Mar 10, 2021 |
Generic Alternatives
The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BluePoint Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE DR 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE DR 20 MG TABLET, manufactured by BluePoint Laboratories, is $0.3832 per EA (NDC 68001044139), effective Sep 30, 2026.
How has the price of OMEPRAZOLE DR 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE DR 20 MG TABLET has declined 23.8%. It has been tracked across 291 weekly CMS publications since Mar 10, 2021.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE DR 20 MG TABLET?
Since Mar 10, 2021, the NADAC for OMEPRAZOLE DR 20 MG TABLET has ranged from a low of $0.3668 (May 22, 2024) to a high of $0.5029 (Mar 10, 2021), with a median of $0.4362 per EA.
Are there cheaper alternatives to OMEPRAZOLE DR 20 MG TABLET?
11 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OMEPRAZOLE DR 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures OMEPRAZOLE DR 20 MG TABLET?
OMEPRAZOLE DR 20 MG TABLET (NDC 68001044139) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.